NCT00647855View on ClinicalTrials.gov

Fasting Study of Levothyroxine Sodium Tablets 300 μg to Synthroid® Tablets 300 μg

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

June 30, 2003

Study Completion Date

June 30, 2003

Conditions
Healthy
Interventions
DRUG

Levothyroxine Sodium Tablets 300 μg

2x300mcg, single dose fasting

DRUG

Synthroid® Tablets 300 μg

2x300mcg, single dose fasting

Trial Locations (1)

58104

PRACS Institute, Ltd., Fargo

Sponsors
All Listed Sponsors
lead

Mylan Pharmaceuticals Inc

INDUSTRY

NCT00647855 - Fasting Study of Levothyroxine Sodium Tablets 300 μg to Synthroid® Tablets 300 μg | Biotech Hunter | Biotech Hunter